J&J | JNJ - Assets


J&J reported $200.89B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
AbbVie USD 136.46B 2.5B Mar/2026
Abbott USD 110.43B 23.72B Mar/2026
Amgen USD 92.5B 1.92B Mar/2026
AstraZeneca USD 114.02B 59M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Biogen USD 29.48B 43.6M Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
Bristol-Myers Squibb USD 86.48B 3.56B Mar/2026
CONMED USD 2.31B 10.81M Mar/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Dexcom USD 6.63B 293.4M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Eli Lilly USD 116.58B 4.1B Mar/2026
Gilead Sciences USD 56.28B 2.74B Mar/2026
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
Globus Medical USD 5.44B 136.79M Mar/2026
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merck USD 128.68B 8.18B Mar/2026
Merit Medical Systems USD 2.72B 33.36M Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Pfizer USD 207.62B 542M Mar/2026
Regeneron Pharmaceuticals USD 40.87B 310.1M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teva Pharmaceutical Industries USD 40.04B 708M Mar/2026
Vertex Pharmaceuticals USD 26.48B 841.4M Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026
Zoetis USD 15.15B 313M Mar/2026